| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 1,074 | 985 | +9.0% |
| EBITDA | 186 | 215 | −13.6% |
| EBITDA margin | 17.3% | 21.9% | −4.5 pts |
| Profit before tax | 118 | 169 | −30.0% |
| Net profit | 88.0 | 143 | −38.4% |
| EPS | ₹9.76 | ₹15.83 | −38.3% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 6,156 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 581 | 581 | 422 | 246 | 208 | ||
| 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | ||
| 0.0 | 0.0 | 0.0 | 3.4 | 3.0 | ||
| 5,575 | — | — | — | — | ||
| 5,357 | 5,268 | 4,320 | 3,163 | 4,045 | ||
| — | +21.9% | +36.6% | −21.8% | — | ||
| 1,047 | 1,076 | 596 | 283 | 643 | ||
| 19.5% | 20.4% | 13.8% | 8.9% | 15.9% | ||
| 700 | 752 | 321 | 15.7 | 395 | ||
| 626 | 681 | 304 | 31.9 | 342 | ||
| 11.7% | 12.9% | 7.1% | 1.0% | 8.5% | ||
| ₹69.40 | ₹75.47 | ₹33.74 | ₹3.53 | ₹37.90 | ||
| — | +123.7% | +854.7% | −90.7% | — | ||
| — | 656 | 604 | 341 | 328 | ||
| — | −497 | −393 | −272 | −244 | ||
| 158 | 158 | 211 | 69.2 | 84.2 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 6,155.7 | |
| - Cash, Equiv & ST Investments | 208.3 | 246.2 | 421.5 | 581.3 | 581.3 | |
| + Minority Interest | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | |
| + Total Debt | 3.0 | 3.4 | 0.0 | 0.0 | 0.0 | |
| Enterprise Value | — | — | — | — | 5,575.0 | |
| Revenue | 4,045.2 | 3,163.0 | 4,319.9 | 5,267.6 | 5,356.5 | |
| Growth %, YoY | — | -21.8 | +36.6 | +21.9 | — | |
| EBITDA | 643.1 | 282.9 | 595.6 | 1,076.2 | 1,046.9 | |
| Margin % | 15.90 | 8.94 | 13.79 | 20.43 | 19.54 | |
| EBIT | 395.0 | 15.7 | 320.9 | 751.7 | 700.2 | |
| Net Income | 342.0 | 31.9 | 304.4 | 681.0 | 626.2 | |
| Margin % | 8.45 | 1.01 | 7.05 | 12.93 | 11.69 | |
| EPS, Adj (current shares) | 37.90 | 3.53 | 33.74 | 75.47 | 69.40 | |
| Growth %, YoY | — | -90.7 | +854.7 | +123.7 | — | |
| Cash from Operations | 328.3 | 341.3 | 603.6 | 655.7 | — | |
| Capital Expenditures | -244.1 | -272.1 | -393.1 | -497.3 | — | |
| Free Cash Flow | 84.2 | 69.2 | 210.6 | 158.4 | 158.4 | |
Prices at the previous close · figures from the company's filings with NSE
Sharda Cropchem (NSE: SHARDACROP) had a market capitalisation of ₹6,156 crore at the previous close (₹682.30 a share), a PE ratio of 9.8 on the last four quarters' profit and a price-to-book ratio of 1.96. In FY26 its consolidated net profit was ₹681 crore on revenue of ₹5,268 crore; in Q1 FY27 (April–June 2026) it was ₹88 crore, down 38.3% year on year. It had no borrowings on 31 March 2026. Promoters held 74.82% of the shares on 30 September 2026.
Sharda Cropchem's PE ratio is 9.8 at the previous close (₹682.30 a share): a market capitalisation of ₹6,156 crore divided by consolidated net profit of ₹626 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹681 crore) it is 9.0.
Sharda Cropchem's price-to-book (PB) ratio is 1.96 at the previous close: a market capitalisation of ₹6,156 crore divided by shareholders' equity (book value) of ₹3,136 crore on 31 March 2026. That is a book value of ₹347.65 per share against a share price of ₹682.30.
Sharda Cropchem's net worth — shareholders' equity in its consolidated balance sheet — was ₹3,136 crore on 31 March 2026, up 25.4% from ₹2,501 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹6,156 crore at the previous close.
Sharda Cropchem's market capitalisation was ₹6,156 crore at the previous close: 9.02 crore shares at ₹682.30 each.
Yes. Sharda Cropchem had no borrowings on 31 March 2026 (consolidated balance sheet), and it held ₹581 crore of cash, bank balances and current investments.
Sharda Cropchem's basic earnings per share (EPS) were ₹75.47 in FY26, against ₹33.74 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹69.41.
Sharda Cropchem's debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹3,137 crore. A year earlier, on 31 March 2025, it was 0.00.
In 2026, Sharda Cropchem has declared two dividends totalling ₹15 a share: ₹6 (interim) with record date 6 February 2026 and ₹9 with record date 7 August 2026.
Promoters held 74.82% of Sharda Cropchem on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Sharda Cropchem's return on equity (ROE) was 24.2% and its return on capital employed (ROCE) was 24.5%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 12.9% and ROCE 12.4%.
Sharda Cropchem's book value per share was ₹347.65 on 31 March 2026: shareholders' equity of ₹3,136 crore divided by the 9.02 crore shares in issue, up 25.4% from ₹277.16 a year earlier. The share price at the previous close was ₹682.30.
On 30 September 2026, Sharda Cropchem's shares were held by promoters 74.82%, foreign portfolio investors (FII/FPI) 3.27%, domestic institutions (DII) 9.22% (including mutual funds at 8.91%) and retail and other non-institutional investors 12.69%. Over the year, FII holding was down 1.99 percentage points from 5.26% and DII holding was down 0.04 percentage points from 9.26%.
Sharda Cropchem's dividend yield is 2.20% at the previous close: dividends of ₹15 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹682.30. They were ₹9 on 7 August 2026 and ₹6 on 6 February 2026 (interim).
In FY26, Sharda Cropchem generated ₹656 crore of cash from operations and spent ₹497 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹158 crore. In FY25 it was ₹211 crore.
In FY26, Sharda Cropchem earned net profit of ₹681 crore on revenue of ₹5,268 crore, against ₹1,922 crore on ₹51,839 crore for UPL. Sharda Cropchem's operating margin was 14.3% (UPL 11.6%) and its return on equity 24.2% (UPL 6.0%).
Sharda Cropchem's latest results are for Q1 FY27 (April–June 2026), filed on 29 July 2026: consolidated net profit ₹88 crore, down 38.3% from ₹143 crore in Q1 FY26; revenue from operations ₹1,074 crore, up 9.0% year on year.
In FY26 (April 2025–March 2026), Sharda Cropchem's consolidated net profit was ₹681 crore, up 123.7% from ₹304 crore in FY25, on revenue from operations of ₹5,268 crore (up 21.9%). Over three years, from FY23, net profit was up 99.1%.
Sharda Cropchem will announce its Q2 FY27 results (July–September 2026) on Friday, 30 October 2026, the date of the board meeting it has notified to the exchanges.
On FY26 consolidated figures, against UPL, PI Industries and Styrenix Performance Materials: Sharda Cropchem's operating margin of 14.3% is the second highest of the four (UPL 11.6%, PI Industries 19.3%, Styrenix Performance Materials 6.7%; peer average 12.5%); its return on equity of 24.2% is the highest of the four (UPL 6.0%, PI Industries 12.2%, Styrenix Performance Materials 14.4%; peer average 10.9%); its revenue growth over three years of 9.2% a year is the second highest of the four (UPL −1.1% a year, PI Industries 1.1% a year, Styrenix Performance Materials 13.2% a year; peer average 4.4% a year).
From Sharda Cropchem's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.